Condition: Stable Angina · Multivessel Coronary Artery Disease · Sponsor: Imperial College London
ORBITA-MOON is a double-blinded, placebo-controlled experimental study that aims to understand how the different coronary artery stenoses contribute to overall clinical angina in patients with multi-vessel coronary artery disease. This study will investigate the symptoms conferred by each stenosis, induced by experimental ischaemia, for 60 patients with multi-vessel coronary artery disease.
This description comes directly from the study's public registry record.
Shayna Chotai, MBBS MRCP · 02075945735 · s.chotai@imperial.ac.uk
Rasha Al-Lamee, PhD MRCP · 02075945735 · r.al-lamee13@imperial.ac.uk
Always discuss trial participation with your own doctor first.
| Essex Cardiothoracic Centre | Basildon, United Kingdom | Recruiting |
| Royal Bournemouth Hospital | Bournemouth, United Kingdom | Recruiting |
| Royal Sussex County Hospital | Brighton, United Kingdom | Recruiting |
| Imperial College NHS Trust | London, United Kingdom | Recruiting |
| Royal Free London NHS Foundation Trust | London, United Kingdom | Recruiting |
| St Georges University Hospital | London, United Kingdom | Recruiting |
| Nottingham City Hospital | Nottingham, United Kingdom | Recruiting |
| Portsmouth Hospitals University NHS Trust | Portsmouth, United Kingdom | Not Yet Recruiting |
| University Hospital Southampton | Southampton, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06400290